L'Oréal takes majority stake in Innovist, valuing Bare Anatomy parent at up to $450M
L'Oréal has signed to acquire a majority stake in Innovist, parent of Bare Anatomy and Chemist at Play, at a reported $350-450M (Rs 3,240-4,170 crore) valuation. The deal, closing in coming months, would mark India's largest beauty D2C acquisition, dwarfing HUL-Minimalist (Rs 2,955 cr) and HUL-Oziva (Rs 824 cr).
L'Oréal signed an agreement to acquire majority stake in Innovist, parent of Bare Anatomy and Chemist at Play, reportedly valuing the D2C personal care firm at $350-450M, potentially India's largest beauty D2C acquisition.
Also reported by
- Entrackr — Same time